Anti-CD19/BCMA U CAR-T cell
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Anti-CD19/BCMA U CAR-T cell, covering 2026-02-25 to 2026-02-25. Get the full timeline:
Most recent: Clinical Trial Update: Exploratory Clinical Study on the Safety and Efficacy of Anti- CD19/BCMA U CAR-T Cell Injection for the Treatment of Relapsed/Refractory Autoimmune Diseases [EARLY_Phase 1]